OpenAI on October 21, 2026 announced that it, PerturbAI, and Scripps Research used thousands of AI agents powered by GPT-Rosalind to analyze existing experimental data from millions of mouse brain ...
("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies designed to ...
Discover how researchers are looking beyond individual neurons to understand how genetic variations shape activity across ...
It was possible to protect the brain from Alzheimer's-related damage without removing abnormal protein accumulations. In an experiment on mice, scientists blocked the path of immune cells involved in ...
Evolutionary and computational models suggest that higher BK potassium-channel conductance may ease calcium-dependent ...
Against this backdrop, we turn our attention to a company driven by a clear mission: to extend survival for people living with ALS - Clene Inc. ( CLNN) For comments and feedback contact: ...
A six-brain sequencing study found that Alzheimer’s-associated tetraploid neurons carried excess low-frequency somatic single ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results